US Map / Delaware
State DE

Clinical Trials in Delaware

Delaware is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Delaware and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 36 actively recruiting studies with Delaware sites out of 36 registered in total. The busiest research areas in Delaware are Multiple Myeloma, Non Small Cell Lung Cancer, Asthma. Leading sponsors running trials in the state include National Cancer Institute (NCI), Nemours Children's Clinic, Children's Hospital Medical Center, Cincinnati. By stage, Delaware trials break down as Phase 1 (2), Phase 2 (5), Phase 3 (14), Phase 4 (4).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
36
Recruiting Now
36
← Back to US Map
Top Conditions in Delaware
Multiple Myeloma (2)Non Small Cell Lung Cancer (2)Asthma (1)Advanced Malignant Solid Neoplasm (1)Anatomic Stage III Breast Cancer AJCC v8 (1)Anatomic Stage IV Breast Cancer AJCC v8 (1)Locally Advanced Malignant Solid Neoplasm (1)Malignant Female Reproductive System Neoplasm (1)Metastatic HER2-Negative Breast Carcinoma (1)Metastatic Malignant Solid Neoplasm (1)Recurrent Endometrial Carcinoma (1)Recurrent Fallopian Tube Carcinoma (1)

Frequently Asked Questions — Clinical Trials in Delaware

How many clinical trials are currently recruiting in Delaware?
ClinicalMetric currently tracks 36 actively recruiting clinical trials with at least one location in Delaware. The total number of registered studies—including active but not currently enrolling trials—is 36. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Delaware?
Delaware hosts clinical trials across a broad range of medical conditions, including Multiple Myeloma, Non Small Cell Lung Cancer, Asthma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Delaware serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Delaware?
To join a clinical trial in Delaware, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Delaware maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Delaware

NCT05270213 Phase 1
Recruiting
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Condition
Advanced Cancer
Enrollment
164 pts
Location
United States
Sponsor
Riboscience, LLC.
View Trial →
NCT06422806 Phase 3
Recruiting
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone f...
Condition
Metastatic Dedifferentiated Liposarcoma
Enrollment
365 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT00736749 N/A
Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Gro...
Condition
Hematopoietic Cell Transplantation Recipient
Enrollment
25,000 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
View Trial →
NCT05006482 Phase 3
Recruiting
Geriatric Evaluation and Management With Survivorship Health Education for Older...
Condition
Lymphoma
Enrollment
668 pts
Location
United States
Sponsor
University of Rochester
View Trial →
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
View Trial →
NCT03072927 N/A
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Condition
Lumbar Spinal Stenosis
Enrollment
8,000 pts
Location
United States
Sponsor
Stryker Instruments
View Trial →
NCT07415031 Phase 2
Recruiting
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated ...
Condition
Solid Tumors
Enrollment
170 pts
Location
United States, Australia, Belgium
Sponsor
Mirati Therapeutics Inc.
View Trial →
NCT05678530 N/A
Recruiting
Observational, Non-Interventional Study Supporting Validation of eVO2peak Using ...
Condition
Cardiopulmonary
Enrollment
2,000 pts
Location
United States, Canada
Sponsor
Prolaio
View Trial →
NCT06824064 Phase 2
Recruiting
Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Col...
Condition
Metastatic Colorectal Cancer
Enrollment
150 pts
Location
United States, Puerto Rico, Vietnam
Sponsor
Riboscience, LLC.
View Trial →
NCT06500273 Phase 2
Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Condition
Large B-cell Lymphoma
Enrollment
250 pts
Location
United States, Australia, Canada
Sponsor
Allogene Therapeutics
View Trial →
NCT07722611 Phase 2, Phase 3
Recruiting
A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-...
Condition
Polycythemia Vera
Enrollment
380 pts
Location
United States, Canada, Israel
Sponsor
Merck Sharp & Dohme LLC
View Trial →
Page 2 of 2 — 36 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology